With the rapid growth of overseas medical tourism families, overseas medical tourism has become an international normal. Medical tourism is a new growth point for the global economy. More countries will develop medical tourism as an important means of promoting their medical technology and economic development. What is more noteworthy is that the rapid development of the Asia-Pacific tourism industry has formed a three-legged and three-point situation in Europe and the United States. The Asia-Pacific region will become the most promising region for medical tourism. On November 18th, 2016, the 5th China Overseas Medical Tourism Exhibition was held at the Beijing-China International Exhibition Center. As the largest medical tourism exhibition in China, it has attracted exhibitors from 12 countries and regions including the United States, Germany, South Korea, Japan, Thailand, Taiwan, and Hong Kong. Nearly 100 top global companies will participate, attracting 20,000 high-end people to visit. As an overseas medical leader, Kang Changrong was invited to participate in this meeting. Gu Xin, chairman of Kang Changrong, believes that medical tourism is an export-oriented industry, and its PPP (Public-Private-Partnership) rules should focus on the international rules, which will not only enhance the investment in medical tourism projects. Attractive, even attracting the enthusiastic participation of overseas capital. With the ppp model, there will be a good clustering effect on the brand image of the local medical industry and tourism. At present, the Kang Changrong anti-cancer radar project has received 20 million first round of start-up funds. The technical support party, supervisor and supporter of the project is the Japan Dezhou Association. The project has been settled in Shanghai and cooperated with Shanghai International Medical Center. International leading early cancer screening technology and talents to achieve cancer "early detection, early diagnosis, early treatment". Gu Xin also said, "At present, the overseas medical industry is mixed. There are very few organizations with business experience in this area, and most of them are non-travel agencies, business consulting companies, etc., and service awareness is not available. Many practitioners find medical institutions. After that, the lack of the most basic investigation of the background, qualifications and other information of medical institutions, eager to form a product profit, regardless of user experience." Shaanxi Hongbaiyi Biotech Co., Ltd. , https://www.sxhongbaiyi.com.png)
.png)